{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:40:45Z","timestamp":1785897645655,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM115516"],"award-info":[{"award-number":["U54GM115516"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM139745"],"award-info":[{"award-number":["P20 GM139745"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dadr.2025.100397","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:51:47Z","timestamp":1764175907000},"page":"100397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Geographic differences in buprenorphine and methadone prescribing for surgical patients with opioid use disorder"],"prefix":"10.1016","volume":"18","author":[{"given":"Caitlin P.","family":"Coates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret McGlothlin","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-6134","authenticated-orcid":false,"given":"Janelle M.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-6375","authenticated-orcid":false,"given":"Wendy Y.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7573-2164","authenticated-orcid":false,"given":"Aurora N.","family":"Quaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2025.100397_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.2024.11977","article-title":"Major gaps in the cascade of care for opioid use disorder: implications for clinical practice","volume":"332","author":"Arwady","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2025.100397_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.25999","article-title":"Buprenorphine prescribing characteristics following relaxation of x-waiver training requirements","volume":"7","author":"Christine","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100397_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.dadr.2025.100397_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-021-00282-2","article-title":"Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018","volume":"17","author":"Conway","year":"2022","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.dadr.2025.100397_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5055\/jom.2022.0689","article-title":"Comparison of PACU length of stay and opioid requirements of patients maintained on buprenorphine or methadone for opioid use disorder","volume":"18","author":"Dale","year":"2022","journal-title":"J. Opioid Manag"},{"key":"10.1016\/j.dadr.2025.100397_bib6","unstructured":"Economic Research Service, 2025. Rural-Urban Commuting Area Codes--Users' Guide. \u3008https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/users-guide\u3009 (accessed 11 August 2025)."},{"key":"10.1016\/j.dadr.2025.100397_bib7","article-title":"Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare","volume":"157","author":"Gibbons","year":"2024","journal-title":"J. Subst. Use Addict. Treat."},{"key":"10.1016\/j.dadr.2025.100397_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.dadr.2025.100397_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108927","article-title":"Racial inequity in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use","volume":"227","author":"Hollander","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100397_bib10","unstructured":"IQVIA Government Solutions Inc, 2024. Buprenorphine Treatment for Substance Use Disorder. \u3008https:\/\/deadiversion.usdoj.gov\/pubs\/docs\/IQVIA-Buprenorphine-for-SUD-v3.pdf\u3009 (accessed 11 August 2025)."},{"key":"10.1016\/j.dadr.2025.100397_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1073110518782951","article-title":"Improving Rural Access to Opioid Treatment Programs","volume":"46","author":"Johnson","year":"2018","journal-title":"J. Law Med Ethics"},{"key":"10.1016\/j.dadr.2025.100397_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100397_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/pm\/pny019","article-title":"Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period","volume":"20","author":"Lembke","year":"2019","journal-title":"Pain. Med."},{"key":"10.1016\/j.dadr.2025.100397_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11606-002-0041-6","article-title":"Policy progress for physician treatment of opiate addiction","volume":"17","author":"Merrill","year":"2002","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2025.100397_bib15","first-page":"042","article-title":"Tackling the rural opioid crisis in the United States (U.S.): strategies for comprehensive intervention and resilience building","volume":"9","author":"Oladapo","year":"2024","journal-title":"Int Arch. Addict. Res Med"},{"key":"10.1016\/j.dadr.2025.100397_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001191","article-title":"Current state of perioperative buprenorphine management-a national provider survey","author":"Quaye","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100397_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5055\/jom.0823","article-title":"Post-operative pain control in patients on buprenorphine or methadone for opioid use disorder","volume":"20","author":"Quaye","year":"2024","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.dadr.2025.100397_bib18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/pm\/pny217","article-title":"Perioperative Management of Buprenorphine: Solving the Conundrum","volume":"20","author":"Quaye","year":"2019","journal-title":"Pain. Med."},{"key":"10.1016\/j.dadr.2025.100397_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2025.100397_bib20","first-page":"17","volume":"63","author":"Substance Abuse and Mental Health Services Administration","year":"2023"},{"key":"10.1016\/j.dadr.2025.100397_bib21","unstructured":"Substance Abuse and Mental Health Services Administration, 2023b. Waiver Elimination. \u3008https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/waiver-elimination-mat-act\u3009 (accessed 11 August 2025)."},{"key":"10.1016\/j.dadr.2025.100397_bib22","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796025100085","article-title":"Global, regional, and national trends and burden of opioid use disorder in individuals aged 15 years and above: 1990\u20132021 and projections to 2040","volume":"34","author":"Wang","year":"2025","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.dadr.2025.100397_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1213\/ANE.0000000000003477","article-title":"Opioid Use Disorders: Perioperative Management of a Special Population","volume":"127","author":"Ward","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.dadr.2025.100397_bib24","article-title":"Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study","volume":"28","author":"Williams","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.dadr.2025.100397_bib25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s11606-023-08027-4","article-title":"Access to medications for opioid use disorder in rural versus urban veterans health administration facilities","volume":"38","author":"Wyse","year":"2023","journal-title":"J. Gen. Intern. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:06:37Z","timestamp":1773871597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"alternative-id":["S2772724625000800"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100397","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic differences in buprenorphine and methadone prescribing for surgical patients with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100397"}}